AI Pre MLR Content Intelligence
The Challenge
Pharmaceutical organizations are managing growing volumes of content across brands, markets and channels, while MLR processes remain highly manual and review-intensive. As a result, issues surface late, rework builds up, and reviewers spend time on repetitive checks instead of high-value judgment.
Key Challenges
- Manual Evidence Validation:
Reviewers spend significant time assessing claims, references and supporting evidence. - Fragmented Review Intelligence:
Findings, decisions and historical precedents are not consistently reused across future content. - Limited Visibility into Review Risk:
Teams lack an early view of content readiness and potential review complexity. - Late-Stage Issue Identification:
Compliance and content issues often surface only once formal review begins. - Repeated Review Cycles:
Revisions trigger additional rounds, increasing time and reviewer workload.
Our Solution
An AI-powered intelligence layer across the content lifecycle that combines content intelligence, evidence grounding, compliance intelligence and human-in-the-loop review. It sits across the existing content ecosystem, so organizations do not need to replace their systems of record.
Intelligent Pre-MLR Review:
AI assesses content against relevant governance and compliance requirements before formal submission.
Claim & Evidence Intelligence:
AI connects claims with relevant supporting evidence and identifies potential gaps or inconsistencies.
Risk & Readiness Intelligence:
Content is assessed for potential areas of review risk, enabling teams to prioritize remediation before submission.
Content Compliance & Brand Governance:
Assesses content against governed compliance, branding and presentation standards to identify potential issues before formal MLR review.
Contextual Review Intelligence:
Findings are surfaced in context with supporting rationale, enabling faster understanding and resolution.
The Outcomes
The platform transforms MLR from a downstream approval checkpoint into a proactive intelligence capability - enabling earlier risk identification, more focused reviews and continuous organizational learning.
Earlier Risk Identification:
Surface potential content and compliance issues before formal MLR submission.
Targeted Re-Review:
Focus subsequent reviews on meaningful changes, reducing unnecessary review of unchanged content.
Higher-Value Reviewer Engagement:
Shift reviewer effort from repetitive checks toward critical Medical, Legal and Regulatory judgment.
Improved Content Readiness:
Provide earlier visibility into content readiness and potential review risks.
Similar Case Studies
.jpg)
.jpg)
.webp)
